Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Int J Mol Sci
2023 Mar 28;247:. doi: 10.3390/ijms24076367.
Show Gene links
Show Anatomy links
Investigation of the Entry Pathway and Molecular Nature of σ1 Receptor Ligands.
Pascarella G
,
Antonelli L
,
Narzi D
,
Battista T
,
Fiorillo A
,
Colotti G
,
Guidoni L
,
Morea V
,
Ilari A
.
???displayArticle.abstract???
The σ1 receptor (σ1-R) is an enigmatic endoplasmic reticulum resident transmembrane protein implicated in a variety of central nervous system disorders and whose agonists have neuroprotective activity. In spite of σ1-R's physio-pathological and pharmacological importance, two of the most important features required to fully understand σ1-R function, namely the receptor endogenous ligand(s) and the molecular mechanism of ligand access to the binding site, have not yet been unequivocally determined. In this work, we performed molecular dynamics (MD) simulations to help clarify the potential route of access of ligand(s) to the σ1-R binding site, on which discordant results had been reported in the literature. Further, we combined computational and experimental procedures (i.e., virtual screening (VS), electron density map fitting and fluorescence titration experiments) to provide indications about the nature of σ1-R endogenous ligand(s). Our MD simulations on human σ1-R suggested that ligands access the binding site through a cavity that opens on the protein surface in contact with the membrane, in agreement with previous experimental studies on σ1-R from Xenopus laevis. Additionally, steroids were found to be among the preferred σ1-R ligands predicted by VS, and 16,17-didehydroprogesterone was shown by fluorescence titration to bind human σ1-R, with significantly higher affinity than the prototypic σ1-R ligand pridopidine in the same essay. These results support the hypothesis that steroids are among the most important physiological σ1-R ligands.
Banister,
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
2012, Pubmed
Banister,
A σ(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).
2012,
Pubmed
Battista,
Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells.
2021,
Pubmed
Bermack,
Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus.
2005,
Pubmed
Berman,
The Protein Data Bank.
2000,
Pubmed
Bolton,
PubChem3D: a new resource for scientists.
2011,
Pubmed
Bussi,
Canonical sampling through velocity rescaling.
2007,
Pubmed
Collaborative Computational Project, Number 4,
The CCP4 suite: programs for protein crystallography.
1994,
Pubmed
Duan,
A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.
2003,
Pubmed
Emsley,
Coot: model-building tools for molecular graphics.
2004,
Pubmed
Escribá,
Membrane lipid therapy: Modulation of the cell membrane composition and structure as a molecular base for drug discovery and new disease treatment.
2015,
Pubmed
Fukunaga,
The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis.
2015,
Pubmed
Glennon,
Structural features important for sigma 1 receptor binding.
1994,
Pubmed
Guex,
SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.
1997,
Pubmed
Gund,
Molecular modeling of sigma 1 receptor ligands: a model of binding conformational and electrostatic considerations.
2004,
Pubmed
Hastings,
ChEBI in 2016: Improved services and an expanding collection of metabolites.
2016,
Pubmed
Hoover,
Canonical dynamics: Equilibrium phase-space distributions.
1985,
Pubmed
Huey,
A semiempirical free energy force field with charge-based desolvation.
2007,
Pubmed
Jordá,
Regulation of Ergosterol Biosynthesis in Saccharomyces cerevisiae.
2020,
Pubmed
Jumper,
Highly accurate protein structure prediction with AlphaFold.
2021,
Pubmed
Jämbeck,
Derivation and systematic validation of a refined all-atom force field for phosphatidylcholine lipids.
2012,
Pubmed
Kanehisa,
KEGG: kyoto encyclopedia of genes and genomes.
2000,
Pubmed
Kim,
Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding.
2010,
Pubmed
Knight,
MemGen: a general web server for the setup of lipid membrane simulation systems.
2015,
Pubmed
Laggner,
Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening.
2005,
Pubmed
Li,
Very fast empirical prediction and rationalization of protein pKa values.
2005,
Pubmed
Long,
AceDRG: a stereochemical description generator for ligands.
2017,
Pubmed
Longhitano,
Sigma-1 and Sigma-2 receptor ligands induce apoptosis and autophagy but have opposite effect on cell proliferation in uveal melanoma.
2017,
Pubmed
Marsch,
7,8-benzoflavone binding to human cytochrome P450 3A4 reveals complex fluorescence quenching, suggesting binding at multiple protein sites.
2018,
Pubmed
Maurice,
Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism.
1998,
Pubmed
Maurice,
Modulation by neurosteroids of the in vivo (+)-[3H]SKF-10,047 binding to sigma 1 receptors in the mouse forebrain.
1996,
Pubmed
Meng,
An open-like conformation of the sigma-1 receptor reveals its ligand entry pathway.
2022,
Pubmed
,
Xenbase
Mishra,
The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands.
2015,
Pubmed
Morales-Lázaro,
Molecular Interplay Between the Sigma-1 Receptor, Steroids, and Ion Channels.
2019,
Pubmed
Morris,
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.
2009,
Pubmed
Murshudov,
Refinement of macromolecular structures by the maximum-likelihood method.
1997,
Pubmed
Nguyen,
Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection.
2017,
Pubmed
Oberdorf,
5D-QSAR for spirocyclic sigma1 receptor ligands by Quasar receptor surface modeling.
2010,
Pubmed
Oyer,
Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes.
2019,
Pubmed
Pascual,
A New Pharmacophore Model for the Design of Sigma-1 Ligands Validated on a Large Experimental Dataset.
2019,
Pubmed
Pettersen,
UCSF Chimera--a visualization system for exploratory research and analysis.
2004,
Pubmed
Pierce,
Routine Access to Millisecond Time Scale Events with Accelerated Molecular Dynamics.
2012,
Pubmed
Ramirez-Gaona,
YMDB 2.0: a significantly expanded version of the yeast metabolome database.
2017,
Pubmed
Rossino,
New Insights into the Opening of the Occluded Ligand-Binding Pocket of Sigma1 Receptor: Binding of a Novel Bivalent RC-33 Derivative.
2020,
Pubmed
Sahlholm,
The dopamine stabilizers ACR16 and (-)-OSU6162 display nanomolar affinities at the σ-1 receptor.
2013,
Pubmed
Schmidt,
Crystal structure of the human σ1 receptor.
2016,
Pubmed
Schmidt,
Structural basis for σ1 receptor ligand recognition.
2018,
Pubmed
Seth,
Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptor.
2001,
Pubmed
Sharma,
The Sigma-1 receptor is an ER-localized type II membrane protein.
2021,
Pubmed
Sterling,
ZINC 15--Ligand Discovery for Everyone.
2015,
Pubmed
Su,
Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems.
1988,
Pubmed
Sud,
LMSD: LIPID MAPS structure database.
2007,
Pubmed
Trott,
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.
2010,
Pubmed
Van Der Spoel,
GROMACS: fast, flexible, and free.
2005,
Pubmed
Varadi,
AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models.
2022,
Pubmed
Winn,
Overview of the CCP4 suite and current developments.
2011,
Pubmed
Wishart,
DrugBank 5.0: a major update to the DrugBank database for 2018.
2018,
Pubmed
Yang,
Sigma-2 Receptor-A Potential Target for Cancer/Alzheimer's Disease Treatment via Its Regulation of Cholesterol Homeostasis.
2020,
Pubmed
Zampieri,
Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma(1) receptor ligands based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives.
2009,
Pubmed